Mechanism of Action of Fibrates
Fibrates work by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha), a nuclear receptor that regulates multiple genes controlling lipid metabolism, leading to reduced triglycerides, increased HDL-cholesterol, and modest LDL-cholesterol reduction. 1
Primary Molecular Mechanism
- Fibrates bind to and activate PPAR-alpha, a nuclear transcription factor that belongs to the nuclear hormone receptor superfamily 2, 3, 4
- Once activated, PPAR-alpha binds to peroxisome proliferator response elements (PPREs) located in the promoter regions of target genes, modulating their transcription 3, 5
Effects on Triglyceride Metabolism
Fibrates reduce serum triglycerides through two complementary pathways:
- Enhanced catabolism: Fibrates increase lipoprotein lipase (LPL) gene transcription and simultaneously decrease apolipoprotein C-III (apoC-III) gene transcription, resulting in accelerated breakdown of triglyceride-rich lipoproteins 2, 4
- Reduced hepatic production: Fibrates stimulate hepatic fatty acid uptake and increase mitochondrial beta-oxidation of fatty acids, while simultaneously reducing fatty acid and triglyceride synthesis, leading to decreased VLDL production 2, 4
- Fibrates also increase apolipoprotein A-V expression, which further enhances triglyceride catabolism 2
Effects on HDL-Cholesterol
- Fibrates increase HDL-cholesterol levels by stimulating transcription of apolipoprotein A-I and apolipoprotein A-II genes, the major protein components of HDL particles 2, 3, 4
- This PPAR-alpha-mediated increase in HDL apolipoprotein synthesis results in higher circulating HDL-cholesterol concentrations 4
Effects on LDL-Cholesterol and VLDL
- Fibrates reduce serum LDL-cholesterol and very low-density lipoprotein (VLDL) levels through PPAR-alpha activation 1
- They also improve LDL-cholesterol quality, making particles less atherogenic 1
Additional Metabolic Effects
- Fatty acid metabolism: Fibrates increase cellular fatty acid uptake via fatty acid transport protein, enhance conversion to acyl-CoA derivatives through acyl-CoA synthetase, and promote catabolism through beta-oxidation pathways 2, 5
- Anti-inflammatory properties: Fibrates function as anti-inflammatory molecules through indirect modulation of nuclear factor-kappa B (NF-κB) activity, which may contribute to their anti-atherosclerotic effects beyond lipid modification 5
Clinical Lipid Effects
The magnitude of lipid changes with fibrate therapy is substantial:
- Triglyceride reduction: 30-50% 1
- HDL-cholesterol increase: modest elevation 1
- LDL-cholesterol reduction: variable, generally modest 1
Important Clinical Context
- Post-hoc analyses demonstrate fibrates reduce coronary heart disease events particularly in patients with high triglycerides and low HDL-cholesterol, especially those with diabetes or metabolic syndrome 1
- Fenofibrate does not interfere with statin catabolism, making combination therapy safer than with other fibrates regarding myopathy risk 1